Exhibit 99.2
ASX ANNOUNCEMENT
28 July 2026
Notice Under Section 708A(5)(e) of the Corporations Act 2001
This notice is given by Radiopharm Theranostics Limited (ASX:RAD) (‘RAD’ or the ‘Company’) undersection 708A(5)(e) of the Corporations Act 2001 (Cth) (the ‘Corporations Act’)..
| Class of securities: | Ordinary Fully Paid Shares |
| ASX Code | RAD |
| Date of issue | 28 July 2026 |
| Number issued | 384,493,800 |
The Company gives notice under section 708(5)(e) of the Corporations Act that:
| 1 | the Company issued the Shares without disclosure under Part 6D.2 of the Corporations Act; |
| 2 | at the date of this notice, the Company has complied with: |
| a. | the provisions of chapter 2M of the Corporations Act as they apply to the Company; and |
| b. | sections 674 and 674A Corporations Act; and |
| 3 | at the date of this notice, there is no information required to be disclosed by the Company which is ‘excluded information’ (as defined in sections 708A(7) and 708A(8) Corporations Act). |
Amritha Sushil
Joint Company Secretary
Radiopharm Theranostics Limited
Suite 1, Level 3, 62 Lygon Street, Carlton South VIC 3053 Australia
ABN: 57 647 877 889